Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

    Forecasted

    This grant funds a national research network to study how cancer and normal tissues respond biologically to radiation therapy, aiming to improve treatment and discover new therapy opportunities.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Mar 5, 2029$250,000

    Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

    This grant supports the continued operation of national biobanks for collecting, storing, and distributing cancer clinical trial biospecimens to advance translational cancer research.

    HHS-NIH11Due Feb 11, 2027

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 14d$150,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.

    HHS-NIH11Due Nov 5, 2026· 9d$1,750,000